In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
Session

Congress : ESC Congress 2019

Topic : Cardio-Oncology

  • Session type : Symposium
  • Date : 02 September 2019
  • Time : 08:30 - 10:00

5 presentations in this session

Panel discussion.

Congress : ESC Congress 2019

  • Session : Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment

Chemotherapy and the heart: the optimal diagnostic approach to cardiotoxicity

Congress : ESC Congress 2019

  • Session : Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
  • Speaker : T Marwick (Melbourne,AU)

Cardiovascular toxicity associated with immune checkpoint inhibitors.

Congress : ESC Congress 2019

  • Session : Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
  • Speaker : J Moslehi (Nashville,US)

Cardiac impact of radiation therapy

Congress : ESC Congress 2019

  • Session : Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
  • Speaker : M Desai (Cleveland,US)

Cardioprotection in cancer patients - Treating the high risk patient.

Congress : ESC Congress 2019

  • Session : Cardio-oncology: what every cardiologist should know about cardiovascular effects of cancer treatment
  • Speaker : N Maurea (Naples,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are